| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |